《FIGO 2018妇癌报告》—子宫颈癌指南解读

2019-01-30 中国实用妇科与产科杂志.2019,35(1):95-103.

子宫颈癌在全球范围而言是最常见的女性恶性肿瘤之一。宫颈癌在中低收入国家更为常见,发病率位居第二,死亡率位居第三。约85%的新发病例及90%的死亡病例发生在社会经济欠发达地区。

中文标题:

《FIGO 2018妇癌报告》—子宫颈癌指南解读

发布机构:

发布日期:

2019-01-30

简要介绍:

子宫颈癌在全球范围而言是最常见的女性恶性肿瘤之一。宫颈癌在中低收入国家更为常见,发病率位居第二,死亡率位居第三。约85%的新发病例及90%的死亡病例发生在社会经济欠发达地区。 

作者: 中山大学孙逸仙纪念医院 周晖 王东雁 罗铭 林仲秋

拓展指南:子宫相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=《FIGO 2018妇癌报告》—子宫颈癌指南解读)] GetToolGuiderByIdResponse(projectId=1, id=ae4611c001e07113, title=《FIGO 2018妇癌报告》—子宫颈癌指南解读, enTitle=, guiderFrom=中国实用妇科与产科杂志.2019,35(1):95-103., authorId=null, author=, summary=子宫颈癌在全球范围而言是最常见的女性恶性肿瘤之一。宫颈癌在中低收入国家更为常见,发病率位居第二,死亡率位居第三。约85%的新发病例及90%的死亡病例发生在社会经济欠发达地区。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Jan 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>子宫颈癌在全球范围而言是最常见的女性恶性肿瘤之一。宫颈癌在中低收入国家更为常见,发病率位居第二,死亡率位居第三。约85%的新发病例及90%的死亡病例发生在社会经济欠发达地区。 </div> <div><br> </div>作者: 中山大学孙逸仙纪念医院 周晖 王东雁 罗铭 林仲秋 <div><br> </div> 拓展指南:<strong>与<font color=red>子宫</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=d26ce1c001692871" title="2018 WHO建议:应用子宫收缩剂预防产后出血" target=_blank>2018 WHO建议:应用子宫收缩剂预防产后出血</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5ea631c00169258f" title="子宫内膜异位症长期管理中国专家共识" target=_blank>子宫内膜异位症长期管理中国专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=398521c0016916f9" title="排卵障碍性异常子宫出血诊治指南" target=_blank>排卵障碍性异常子宫出血诊治指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=1558f1c00168a33c" title="《FIGO 2018癌症报告》—子宫肉瘤诊治指南解读" target=_blank>《FIGO 2018癌症报告》—子宫肉瘤诊治指南解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=bcb2b1c00168106c" title="子宫内膜癌诊治规范(2018年版)" target=_blank>子宫内膜癌诊治规范(2018年版)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%AD%90%E5%AE%AB" target=_blank>有关子宫更多指南</a></ul>, tagList=[TagDto(tagId=72322, tagName=癌症报告)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21053, categoryName=梅斯医学-宫颈癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8480, appHits=1135, showAppHits=56, pcHits=5880, showPcHits=2372, likes=211, shares=45, comments=4, approvalStatus=1, publishedTime=Sun Feb 24 19:04:03 CST 2019, publishedTimeString=2019-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 24 19:04:03 CST 2019, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 03:32:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=《FIGO 2018妇癌报告》—子宫颈癌指南解读)])
《FIGO 2018妇癌报告》—子宫颈癌指南解读
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1072808, encodeId=c32f10e28084a, content=临床工作规范, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b65726584, createdName=ms9000002039039583, createdTime=Mon Nov 22 11:38:16 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812580, encodeId=c137812580af, content=谢谢楼主分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KibHX5rScicpkiaHKPweuWD0uteiakSOCjnbicPE8vymZ6By4xtVkoemvmiaby7ibmYgYAcsia2NlRrzGZTo/0, createdBy=f3af2052937, createdName=晴天Sarah, createdTime=Sun Aug 23 22:08:58 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803993, encodeId=adea8039938c, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=361f2225166, createdName=1210fc7fm06暂无昵称, createdTime=Wed Jul 22 21:05:52 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2021-11-22 ms9000002039039583

    临床工作规范

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1072808, encodeId=c32f10e28084a, content=临床工作规范, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b65726584, createdName=ms9000002039039583, createdTime=Mon Nov 22 11:38:16 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812580, encodeId=c137812580af, content=谢谢楼主分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KibHX5rScicpkiaHKPweuWD0uteiakSOCjnbicPE8vymZ6By4xtVkoemvmiaby7ibmYgYAcsia2NlRrzGZTo/0, createdBy=f3af2052937, createdName=晴天Sarah, createdTime=Sun Aug 23 22:08:58 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803993, encodeId=adea8039938c, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=361f2225166, createdName=1210fc7fm06暂无昵称, createdTime=Wed Jul 22 21:05:52 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-08-23 晴天Sarah

    谢谢楼主分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1072808, encodeId=c32f10e28084a, content=临床工作规范, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b65726584, createdName=ms9000002039039583, createdTime=Mon Nov 22 11:38:16 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812580, encodeId=c137812580af, content=谢谢楼主分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KibHX5rScicpkiaHKPweuWD0uteiakSOCjnbicPE8vymZ6By4xtVkoemvmiaby7ibmYgYAcsia2NlRrzGZTo/0, createdBy=f3af2052937, createdName=晴天Sarah, createdTime=Sun Aug 23 22:08:58 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803993, encodeId=adea8039938c, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=361f2225166, createdName=1210fc7fm06暂无昵称, createdTime=Wed Jul 22 21:05:52 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-07-22 1210fc7fm06暂无昵称

    很好

    0